Literature DB >> 36034134

Sex differences in brain functional connectivity of hippocampus in mild cognitive impairment.

Jordan Williamson1, Andriy Yabluchanskiy2, Peter Mukli2, Dee H Wu3,4,5,6, William Sonntag2, Carrie Ciro7, Yuan Yang1,4,7,8,9.   

Abstract

Mild cognitive impairment (MCI) is the prodromal stage of Alzheimer's Disease (AD). Prior research shows that females are more impacted by MCI than males. On average females have a greater incidence rate of any dementia and current evidence suggests that they suffer greater cognitive deterioration than males in the same disease stage. Recent research has linked these sex differences to neuroimaging markers of brain pathology, such as hippocampal volumes. Specifically, the rate of hippocampal atrophy affects the progression of AD in females more than males. This study was designed to extend our understanding of the sex-related differences in the brain of participants with MCI. Specifically, we investigated the difference in the hippocampal connectivity to different areas of the brain. The Resting State fMRI and T2 MRI of cognitively normal individuals (n = 40, female = 20) and individuals with MCI (n = 40, female = 20) from the Alzheimer's Disease Neuroimaging Initiative (ADNI) were analyzed using the Functional Connectivity Toolbox (CONN). Our results demonstrate that connectivity of hippocampus to the precuneus cortex and brain stem was significantly stronger in males than in females. These results improve our current understanding of the role of hippocampus-precuneus cortex and hippocampus-brainstem connectivity in sex differences in MCI. Understanding the contribution of impaired functional connectivity sex differences may aid in the development of sex specific precision medicine to manipulate hippocampal-precuneus cortex and hippocampal-brainstem connectivity to decrease the progression of MCI to AD.
Copyright © 2022 Williamson, Yabluchanskiy, Mukli, Wu, Sonntag, Ciro and Yang.

Entities:  

Keywords:  Alzheimer’s disease; functional connectivity; hippocampus; mild cognitive impairment; sex difference

Year:  2022        PMID: 36034134      PMCID: PMC9399646          DOI: 10.3389/fnagi.2022.959394

Source DB:  PubMed          Journal:  Front Aging Neurosci        ISSN: 1663-4365            Impact factor:   5.702


Introduction

According to the CDC, there are 6.2 million people in the United States living with Alzheimer’s Disease (AD) in 2021 (Centers for Disease Control and Prevention, 2021). This disease disproportionately affects females as they constitute more than two-thirds of the AD population (Snyder et al., 2016). The higher prevalence of AD in females has been attributed to females having greater longevity compared to males (Guerreiro and Bras, 2015). Since age is the greatest risk factor for the development of AD, it would be reasonable to state that more females would live long enough to develop AD. However, increasing evidence suggests there are other factors contribute to the sex-specific risk of AD such as genetics, hormonal differences, rate of depression, education level, and sleep disturbances (Andrew and Tierney, 2018; Mielke, 2019; Pearce et al., 2022). The most important predictor is mild cognitive impairment (MCI) that always precedes AD, usually years before meeting the diagnostic criteria of clinical dementia (Petersen, 2004). MCI is defined as cognitive decline greater than expected for a given age but does not notably interfere with daily activities (Salmon, 2011). Current clinical evidence demonstrates about a 20% annual conversion rate of MCI to AD and that more than half of the individuals with MCI progress to dementia within 5 years (Gauthier et al., 2006; Davatzikos et al., 2011; López et al., 2020; McGrattan et al., 2022). In addition to prevalence differences, females experience greater cognitive deterioration than males in the same disease stage (Alzheimer’s Association, 2016) that are also present in individuals with MCI (Sohn et al., 2018). Compared to males with AD, females perform worse on a variety of neuropsychological tasks and have greater total brain atrophy and temporal lobe degeneration (Henderson and Buckwalter, 1994; Chapman et al., 2011; Gumus et al., 2021). Magnetic resonance imaging (MRI) data collected through the Alzheimer’s Disease Neuroimaging Initiative (ADNI) study attested to the faster atrophic rate (Hua et al., 2010). The hippocampus is also known to be affected at the earliest stages of MCI, even before a diagnosis can be made (Braak and Braak, 1995), and hippocampal atrophy has been found to affect the progression of AD only in females (Burke et al., 2019). Recent research revealed additional brain imaging markers that may also contribute to the sex differences in AD and are specifically present in individuals with MCI and that reduced hippocampal volume and any microhemorrhage, regardless of location, are the best MRI features to predict the transition from pre-MCI to MCI (Ferretti et al., 2018; Jiang et al., 2022). Cavedo et al. (2018) found that males with MCI had a higher anterior cingulate cortex amyloid load and glucose hypometabolism in the precuneus, posterior cingulate, and inferior parietal cortex. Similar findings have been reported among cognitively normal adults (Rahman et al., 2020) suggesting that males have a higher brain resilience. However, the role of sex-related differences in hippocampal connectivity during MCI has not been elucidated yet. This study was designed to extend the understanding of the mechanism underlying the sex differences in pathophysiological biomarkers in individuals with MCI. Our hypothesis was that hippocampal functional connectivity (FC) to the precuneus cortex and the brain stem shows sex-and MCI-specific differences. The FC of the hippocampus will be analyzed and compared between females and males with MCI, as well as cognitively normal females and males as controls.

Materials and methods

Data source

The data for this study were extracted from the ADNI[1], which is a publicly accessible dataset available at adni.loni.usc.edu. Launched in 2003, ADNI is a longitudinal, multi-site, cohort study, led by Principal Investigator Michael W. Weiner, MD. The original study, ADNI-1, has been extended three times and the database contains subject data from ADNI-1, ADNI-GO, ADNI-2, and ADNI-3. The overall goal of the studies was to evaluate whether serial magnetic resonance imaging (MRI), positron emission tomography (PET), other biological markers, and clinical and neuropsychological assessment can be combined to measure the progression of mild cognitive impairment (MCI) and early Alzheimer’s disease (AD). For up-to-date information, see www.adni-info.org.

Screening process

The data were screened for subjects with MCI. To eliminate multiple images from the same subject, the data included early MCI (EMCI), late MCI (LMCI), or MCI from the 1-year subject visit of ADNI-1, ADNI-GO, ADNI-2, and ADNI-3. Subjects’ selection was also limited to those with data collected from resting-state functional magnetic resonance imaging (rs-fMRI) and 3.0-Tesla T2 magnetic resonance imaging. A similar search methodology was applied for cognitively normal (CN) subjects. The screening resulted in a total of 40 MCI females, 42 MCI males, 25 CN females, and 20 CN males. To balance the number of subjects in each group, 20 of each group were randomly selected for the study. Demographics of MCI subjects are provided in Table 1. This includes age, Apolipoprotein E (ApoE) genotype, the Mini Mental State Examination (MMSE), the Geriatric Depression (GD) Scale, the Global Clinical Dementia Rating (CDR), and the Functional Activities Questionnaire (FAQ), and the Neuropsychiatric Inventory Questionnaire (NPI-Q). IBM SPSS (IBM Corp. Armonk, NY, United States) was used to run independent t-tests to ensure there was not a statistically significant sex difference in age, MMSE, GD Scale, CDR, FAQ and NPI-Q (P > 0.05). If normal distribution could not be assumed based on the Shapiro–Wilk test, a non-parametric Mann–Whitney test was performed. These values are provided in Table 1.
TABLE 1

Mild cognitive impairment subject demographics.

IDSexAgeApoE genotypeMMSEGD ScaleCDRFAQNPI-Q
S001F74ε3 ε32660.503
S002F65ε4 ε42510.511
S003F71ε4 ε42900.500
S004F80ε3 ε32510.501
S005F70ε3 ε33050.50-
S006F65ε4 ε42771.03010
S007F79ε3 ε32900.542
S008F58ε3 ε43010.503
S009F76ε3 ε42670.548
S010F61ε3 ε32930.550
S011F72ε3 ε42821.01916
S012F72ε3 ε32850.500
S013F84ε3 ε32860.580
S014F69ε3 ε32610.500
S015F72ε3 ε33020.503
S016F72ε3 ε42800.564
S017F81ε3 ε42520.573
S018F77ε3 ε32910.502
S019F67ε3 ε32920.500
S020F63ε3 ε32910.511
S021M68ε3 ε42900.523
S022M72ε3 ε42900.5124
S023M62ε4 ε42900.500
S024M58ε3 ε32500.512
S025M74ε3 ε42820.532
S026M63ε2 ε33010.512
S027M90ε3 ε32620.5411
S028M86ε3 ε32510.563
S029M87ε3 ε4291.1.01012
S030M70ε2 ε42820.528
S031M74ε2 ε33030.502
S032M75ε3 ε42751.0217
S033M69ε3 ε32710.501
S034M74ε3 ε3292100
S035M77ε2 ε32860.578.0
S036M80ε3 ε42131.0224
S037M73ε3 ε43020.522
S038M76ε3 ε33010.511
S039M62ε4 ε42750.537
S040M76ε3 ε32350.534
Female μ ± SD 71 ± 7.1 - 27.7 ± 1.7 2.5 ± 2.4 0.55 ± 0.16 4.4 ± 7.7 3.0 ± 4.1
Male μ ± SD 73 ± 8.5 - 27.5 ± 2.5 2.1 ± 1.9 0.6 ± 0.21 5.0 ± 6.5 4.1 ± 3.5
Between sex t-tests P = 0.44 - P = 0.95 P = 0.58 P = 0.38 P = 0.22 P = 0.12

Bold values represented by Mean±STD and p-values.

Mild cognitive impairment subject demographics. Bold values represented by Mean±STD and p-values.

Analysis of functional connectivity and statistical testing

The subject’s original rs-fMRI and MRI images (NiFTI format) were imported into the NITRC Functional Connectivity Toolbox (CONN) version 20b (Whitfield-Gabrieli and Nieto-Castanon, 2012). CONN utilizes SPM12 (Welcome Department of Cognitive Neurology, United Kingdom) and MATLAB R2020a (MathWorks, Natick, MA, United States) in its processes and by default a combination of the Harvard-Oxford atlas (HOA distributed with FSL[2]) (Smith et al., 2004; Woolrich et al., 2009; Jenkinson et al., 2012) and the Automated Anatomical Labeling (AAL) atlas (Tzourio-Mazoyer et al., 2002). The images were processed through the default functional and structural preprocessing pipeline as detailed in Nieto-Castanon (2020). This included realignment, slice timing correction, coregistration/normalization, segmentation, outlier detection, and smoothing. Additionally, this step extracted the blood-oxygen-level dependent (BOLD) time series from the regions of interest (ROIs) and at the voxels. Next, the images were denoised to remove confounding effects from the BOLD signal through linear regression and band-pass filtering. A quality assurance check was made after the denoising to ensure normalization and that there were no visible artifacts in the data. A seed-to-voxel analysis was conducted for each subject. This analysis created a seed-based connectivity (SBC) map between the ROI (left or right hippocampus) to every voxel of the brain. The SBC map is computed as the Fisher-transformed bivariant correlation coefficients between the ROI BOLD time series and each individual voxel BOLD time series (Whitfield-Gabrieli and Nieto-Castanon, 2012). The mathematical relationship to construct the SBC is shown below where R is the average ROI BOLD timeseries, S is the BOLD timeseries at each voxel, r is the spatial map of Pearson correlation coefficients, and Z is the SBC map of the Fisher-transformed correlation coefficients for the ROI. Finally, F-tests were conducted between the SBC maps to compare differences between groups. For a cortical area to be considered significant, the toolbox used the Gaussian Random Field theory parametric statistics, with a cluster threshold p < 0.05 (FDR-corrected) and voxel threshold p < 0.001 (uncorrected) to control the type I error in multiple comparisons (Worsley et al., 1996). Additionally, the area must have been over 800 voxels large or cover more than 80 percent of a given atlas (specific brain area).

Results

The brain regions identified to be significantly different between the MCI and CN groups are shown in Table 2. The left and right para hippocampal gyrus, hippocampus, and amygdala all had significant between-group differences in both sexes. The regions that had a sex-specific were the Precuneus Cortex and the Brainstem, observed only in males.
TABLE 2

Brain regions with a significant difference between mild cognitive impairment and cognitively normal for each sex.

SexROIBrain area (Atlas)% Atlas covered# Of voxels
Female (FMCI v FCN)Right HippocampusLeft Posterior Para Hippocampal Gyrus89%346
Right Posterior Para Hippocampal Gyrus89%283
Right Hippocampus100%342
Left Hippocampus94%318
Right Amygdala100%342
Left Amygdala97%318
Left HippocampusLeft Posterior Para Hippocampal Gyrus91%354
Right Posterior Para Hippocampal Gyrus90%288
Right Hippocampus98%684
Left Hippocampus100%761
Right Amygdala94%322
Left Amygdala100%327
Male (MMCI v MCN)RightBrain Stem24%1001
HippocampusPrecuneus Cortex18%993
Left Posterior Para Hippocampal Gyrus97%380
Right Posterior Para Hippocampal Gyrus97%308
Right Hippocampus98%685
Left Hippocampus100%760
Right Amygdala100%342
Left Amygdala100%327
LeftBrain Stem20%829
HippocampusPrecuneus Cortex20%1132
Left Posterior Para Hippocampal Gyrus92%358
Right Posterior Para Hippocampal Gyrus94%299
Right Hippocampus98%685
Left Hippocampus100%760
Right Amygdala99%337
Left Amygdala100%327
Brain regions with a significant difference between mild cognitive impairment and cognitively normal for each sex. In MCI, males showed significantly stronger connectivity of the right or left hippocampus to the left or right precuneus cortex, respectively. This difference is shown visually by comparing boxes A and D (see Figures 1–3). There was also a sex specific difference detected in the brain stem. This is visualized in Figure 3.
FIGURE 1

Sex-Specific Pathological Features with Right Hippocampus as ROI. Highlighted display the statistically significant cortical regions between mild cognitive impairment (MCI) and cognitively normal (CN) (p < 0.001) normalized to a 1–10 scale. Orange arrows indicate the areas of difference at the precuneus cortex. Panels (A–C) display MMCI v MCN. Panels (D–F) display FMCI v FCN.

FIGURE 3

Sex-Specific Pathological Features Sagittal View. Highlighted Areas display the statistically significant regions between cognitively normal (CN) and mild cognitive impairment (MCI) (p < 0.001) normalized to a 1–10 scale. Orange circles indicate the area of difference in the brain stem and provide size reference between subplots. (A) Right Hippocampus ROI MMCI v MCN. (B) Left Hippocampus ROI MMCI v MCN. (C) Right Hippocampus ROI FMCI v FCN. (D) Left Hippocampus ROI FMCI v FCN.

Sex-Specific Pathological Features with Right Hippocampus as ROI. Highlighted display the statistically significant cortical regions between mild cognitive impairment (MCI) and cognitively normal (CN) (p < 0.001) normalized to a 1–10 scale. Orange arrows indicate the areas of difference at the precuneus cortex. Panels (A–C) display MMCI v MCN. Panels (D–F) display FMCI v FCN. Sex-Specific Pathological Features with Left Hippocampus as ROI. Highlighted areas display the statistically significant cortical regions between mild cognitive impairment (MCI) and cognitively normal (CN) (p < 0.001) normalized to a 1–10 scale. Orange arrows indicate the area of difference at the precuneus cortex. Panels (A–C) display MMCI v MCN. Panels (D–F) display FMCI v FCN. Sex-Specific Pathological Features Sagittal View. Highlighted Areas display the statistically significant regions between cognitively normal (CN) and mild cognitive impairment (MCI) (p < 0.001) normalized to a 1–10 scale. Orange circles indicate the area of difference in the brain stem and provide size reference between subplots. (A) Right Hippocampus ROI MMCI v MCN. (B) Left Hippocampus ROI MMCI v MCN. (C) Right Hippocampus ROI FMCI v FCN. (D) Left Hippocampus ROI FMCI v FCN.

Discussion

This study supports that there are sex differences in pathophysiological biomarkers of the brain in MCI. Specifically, it extends our current understanding of the role of the hippocampus in these differences. We demonstrate that hippocampal functional connectivity differs to the precuneus cortex and the brain stem between males and females. The differences found between the MCI and cognitively normal groups across sexes (posterior para hippocampal gyrus, hippocampus, and amygdala) are consistent with prior studies. The posterior para hippocampal gyrus is the cortical ridge in the medial temporal lobe. It contains the hippocampus (covering it medially) and amygdala (covering it anteromedially) (Goel, 2015). These structures are highly integrated and significant in the process of associative memory (Weniger et al., 2004). It has been shown that functional connectivity between the hippocampus and amygdala to different regions of the brain is disrupted in MCI (Wang et al., 2011; Ortner et al., 2016). This is consistent with our findings. The role of the precuneus cortex is consistent with other literature highlighting its importance in the development of AD. The precuneus cortex is in the posteromedial portion of the parietal lobe. This area has a central role in a wide range of integrated tasks, including visuo-spatial imagery, episodic memory retrieval, and self-processing operations (Cavanna and Trimble, 2006). The precuneus cortex has been shown to have significantly greater activation in MCI, compared to controls, during visual encoding memory tasks (Rami et al., 2012). Prior studies have shown that functional connectivity between the hippocampus and precuneus cortex differs between individuals with early AD and healthy controls (Kim et al., 2013; Yokoi et al., 2018). However, these studies do not extend to differences between sexes. It has been shown that in individuals with subjective memory complaints, males compared to females had glucose hypometabolism in the precuneus cortex (Cavedo et al., 2018). Our findings extend this knowledge of differences between males and females in the precuneus cortex and show that the effect of MCI on the hippocampal-precuneus cortex functional connectivity may be contributing to the high prevalence of MCI in females. Previous studies observed that functional connectivity of the locus coeruleus (LC) and the ventral tegmental area (VTA) in the midbrain of the brain stem differ in individuals with AD and MCI. Specifically, the connectivity between the VTA and the para hippocampal gyrus and cerebellar vermis were associated with the occurrence of neuropsychiatric symptoms of AD (Serra et al., 2018). Other studies showed that reduced connectivity between the LC and para hippocampal gyrus in MCI was correlated with memory performance (Jacobs et al., 2015). The difference in functional connectivity seen between males and females in this study extends these known connectivity differences seen between MCI and controls to an additional sex difference. This may be a factor in the observed worse neuropsychological tasks seen in females. The sex differences observed in MCI have also been attributed to other factors besides functional connectivity. For example, cognitive reserve, referring to education and premorbid intelligence (IQ), is associated with the progression of MCI to AD (Osone et al., 2014). Furthermore, Giacomucci et al. (2022) reported that sex interacts with cognitive reserve and influences the onset and severity of subjective cognitive decline. Additionally, sex differences in the progression of AD from MCI have been correlated with the ApoE ε4 allele, a well-known risk factor for AD. It has been observed that ApoE ε4 is only significantly correlated to the progression of AD in females (Kim et al., 2015). In summary, these findings are significant as they expand our current understanding of the role of the hippocampus-precuneus cortex and hippocampus-brainstem connectivity in sex differences in MCI. Understanding these sex differences in pathophysiology may aid in the development of sex-specific precision medicine to manipulate hippocampal-precuneus cortex and hippocampal-brainstem connectivity to decrease the progression of MCI to AD. Our findings provide the rationale for sex-specific interventions such as cognitive training (Hardcastle et al., 2022) and neuro-navigation guided, targeted non-invasive brain stimulation (Mackenbach et al., 2020; Yang et al., 2021) or their combination (Vecchio et al., 2022). Limitations and Future Work are related to this study’s number of subjects. While this research provides preliminary findings on sex differences in functional connectivity of the hippocampus in individuals with MCI, the small sample size (n = 80) is a limitation. Therefore, future work includes increasing sample size in a larger database, as well as expanding functional connectivity from other regions of interest for MCI, in addition to the hippocampus. Furthermore, studies such as these could be furthered by combining mentioned risk factors such as cognitive reserve or genetic differences to explore if there is any connection.

Data availability statement

The original contributions presented in this study are included in the article/supplementary material, further inquiries can be directed to the corresponding author/s.

Author contributions

JW conducted the study and drafted the manuscript. YY contributed to conceptualization, problem solving, and guidance during the conduction of the study. AY, PM, DW, WS, CC, and YY participated in editing the manuscript. All authors contributed to the article and approved the submitted version.
  43 in total

1.  Conn: a functional connectivity toolbox for correlated and anticorrelated brain networks.

Authors:  Susan Whitfield-Gabrieli; Alfonso Nieto-Castanon
Journal:  Brain Connect       Date:  2012-07-19

2.  Baseline and longitudinal patterns of hippocampal connectivity in mild cognitive impairment: evidence from resting state fMRI.

Authors:  Zhiqun Wang; Peipeng Liang; Xiuqin Jia; Zhigang Qi; Lei Yu; Yanhui Yang; Weidong Zhou; Jie Lu; Kuncheng Li
Journal:  J Neurol Sci       Date:  2011-08-06       Impact factor: 3.181

3.  A multivariate model of time to conversion from mild cognitive impairment to Alzheimer's disease.

Authors:  María Eugenia López; Agustín Turrero; Pablo Cuesta; Inmaculada Concepción Rodríguez-Rojo; Ana Barabash; Alberto Marcos; Fernando Maestú; Alberto Fernández
Journal:  Geroscience       Date:  2020-09-04       Impact factor: 7.713

Review 4.  Sex differences in Alzheimer disease - the gateway to precision medicine.

Authors:  Maria Teresa Ferretti; Maria Florencia Iulita; Enrica Cavedo; Patrizia Andrea Chiesa; Annemarie Schumacher Dimech; Antonella Santuccione Chadha; Francesca Baracchi; Hélène Girouard; Sabina Misoch; Ezio Giacobini; Herman Depypere; Harald Hampel
Journal:  Nat Rev Neurol       Date:  2018-08       Impact factor: 42.937

5.  Sex and Gender Differences in Alzheimer's Disease Dementia.

Authors:  Michelle M Mielke
Journal:  Psychiatr Times       Date:  2018-12-30

6.  2016 Alzheimer's disease facts and figures.

Authors: 
Journal:  Alzheimers Dement       Date:  2016-04       Impact factor: 21.566

7.  Hippocampus-precuneus functional connectivity as an early sign of Alzheimer's disease: a preliminary study using structural and functional magnetic resonance imaging data.

Authors:  Junghoe Kim; Yong-Hwan Kim; Jong-Hwan Lee
Journal:  Brain Res       Date:  2012-12-13       Impact factor: 3.252

Review 8.  FSL.

Authors:  Mark Jenkinson; Christian F Beckmann; Timothy E J Behrens; Mark W Woolrich; Stephen M Smith
Journal:  Neuroimage       Date:  2011-09-16       Impact factor: 6.556

Review 9.  Risk of conversion from mild cognitive impairment to dementia in low- and middle-income countries: A systematic review and meta-analysis.

Authors:  Andrea M McGrattan; Eduwin Pakpahan; Mario Siervo; Devi Mohan; Daniel D Reidpath; Matthew Prina; Pascale Allotey; Yueping Zhu; Chen Shulin; Jennifer Yates; Stella-Maria Paddick; Louise Robinson; Blossom C M Stephan
Journal:  Alzheimers Dement (N Y)       Date:  2022-03-13

10.  Involvement of the Precuneus/Posterior Cingulate Cortex Is Significant for the Development of Alzheimer's Disease: A PET (THK5351, PiB) and Resting fMRI Study.

Authors:  Takamasa Yokoi; Hirohisa Watanabe; Hiroshi Yamaguchi; Epifanio Bagarinao; Michihito Masuda; Kazunori Imai; Aya Ogura; Reiko Ohdake; Kazuya Kawabata; Kazuhiro Hara; Yuichi Riku; Shinsuke Ishigaki; Masahisa Katsuno; Shinichi Miyao; Katsuhiko Kato; Shinji Naganawa; Ryuichi Harada; Nobuyuki Okamura; Kazuhiko Yanai; Mari Yoshida; Gen Sobue
Journal:  Front Aging Neurosci       Date:  2018-10-05       Impact factor: 5.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.